Sandoz stock: October 28 sales update is due for Sandoz stock

Published on 10/19/2026 at 15:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half 2026 sales reached USD 5.78 billion, up 9.90 percent year over year. Sandoz stock costs EUR 83.51 on October 19, 2026 at 3:33 p.m. CEST.

Reporting date and valuation

Sandoz is scheduled to publish third-quarter sales on October 28, 2026.
First-half 2026 sales reached USD 5.78 billion, while biosimilar sales grew 20.00 percent.
Sandoz stock costs EUR 83.51 at Lang & Schwarz on October 19, 2026 at 3:33 p.m. CEST.
Sandoz had a CHF 33.3 billion market capitalization and a P/E ratio of 62.63 as of October 19, 2026.

Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz stock is heading toward its next scheduled sales update on October 28, 2026. The date was reported by Vermögenszentrum in connection with the company's nine-month and third-quarter sales update. Sandoz stock was trading at EUR 83.51 at Lang & Schwarz on October 19, 2026 at 3:33 p.m. CEST.

First-half sales set the baseline

Sandoz reported first-half 2026 sales of USD 5.78 billion, up 9.90 percent from USD 5.27 billion in the first half of 2025. The figures are summarized by Zacks from the company's first-half reporting. Biosimilar sales grew 20.00 percent to USD 1.88 billion, lifting the business to 33.00 percent of total sales.

Price sits near the yearly high

The latest Lang & Schwarz quote was EUR 83.51, with a bid of EUR 83.48 and an ask of EUR 83.54. The home listing on SIX Swiss Exchange was at CHF 76.98 on October 19, 2026 at 3:25 p.m. UTC converted to 5:25 p.m. CEST, according to the structured quote. Its 52-week range was CHF 47.73 to CHF 77.46, putting the home-market price 0.62 percent below the high.

Valuation and the next date

Sandoz had a market capitalization of CHF 33.3 billion, a P/E ratio of 62.63 and a dividend yield of 0.01 percent as of October 19, 2026. The company is listed on SIX Swiss Exchange under ticker SDZ and operates in health care and pharmaceuticals, as documented by 6ix. The October 28 sales update is the next dated company event identified for the stock.

Stock position in one view

The euro quote gives German investors a direct trading reference, while the SIX quotation places the company close to its 52-week peak in Swiss francs. The contrast matters because the two listings use different currencies and trading venues.

Trading frame

Sandoz has expanded biosimilars faster than total sales in the first half of 2026, but the upcoming sales update will show whether that mix continued into the third quarter. The company is listed under ISIN CH1243598427 and its primary exchange is SIX Swiss Exchange.

The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.